[
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Apple, Tesla, GM, Nvidia, Super Micro, MicroStrategy, U.S. Steel, Alibaba, and More",
    "summary": "Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, General Motors is downgraded, and MicroStrategy follows Bitcoin lower.",
    "url": "https://finnhub.io/api/news?id=a9b1ab951a2c8431e738e730c9eb728c7e37c45dc98df8f8ba69e268ee53708b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744057440,
      "headline": "These Stocks Moved the Most Today: Apple, Tesla, GM, Nvidia, Super Micro, MicroStrategy, U.S. Steel, Alibaba, and More",
      "id": 133820742,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, General Motors is downgraded, and MicroStrategy follows Bitcoin lower.",
      "url": "https://finnhub.io/api/news?id=a9b1ab951a2c8431e738e730c9eb728c7e37c45dc98df8f8ba69e268ee53708b"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers",
    "summary": "(Bloomberg) -- Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersThis Skinny Mexico City Tower Is Just 14 Feet Wide on One SideThe Irish Hot Press Is the Low-Tech Laundry Trick the World NeedsBoston Mayor Wu Embraces Trump Resistance as Campaign Heats UpTrump Order on CDFI Fu",
    "url": "https://finnhub.io/api/news?id=60e42533dd8176ff464ab8fd19b8da3ca2ad5369ceb37f68b03bb48318e2d57f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744053492,
      "headline": "Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers",
      "id": 133820743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersThis Skinny Mexico City Tower Is Just 14 Feet Wide on One SideThe Irish Hot Press Is the Low-Tech Laundry Trick the World NeedsBoston Mayor Wu Embraces Trump Resistance as Campaign Heats UpTrump Order on CDFI Fu",
      "url": "https://finnhub.io/api/news?id=60e42533dd8176ff464ab8fd19b8da3ca2ad5369ceb37f68b03bb48318e2d57f"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Stock Is Falling. It Isn’t Just About Tariffs.",
    "summary": "The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as Eli Lilly’s Zepbound.",
    "url": "https://finnhub.io/api/news?id=68c3aab1b16adb4c2c400fedc93196f8b0c8a03daa7a8c114ace349f194fad39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744047780,
      "headline": "Eli Lilly Stock Is Falling. It Isn’t Just About Tariffs.",
      "id": 133741083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as Eli Lilly’s Zepbound.",
      "url": "https://finnhub.io/api/news?id=68c3aab1b16adb4c2c400fedc93196f8b0c8a03daa7a8c114ace349f194fad39"
    }
  },
  {
    "ts": null,
    "headline": "How Markets Solved the GLP-1 Shortage",
    "summary": "How Markets Solved the GLP-1 Shortage",
    "url": "https://finnhub.io/api/news?id=6d5b891a48078a3a423d01a08d65af670717779b761a281021e44788c36c63e4",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744046220,
      "headline": "How Markets Solved the GLP-1 Shortage",
      "id": 133771986,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "How Markets Solved the GLP-1 Shortage",
      "url": "https://finnhub.io/api/news?id=6d5b891a48078a3a423d01a08d65af670717779b761a281021e44788c36c63e4"
    }
  },
  {
    "ts": null,
    "headline": "Novo preparing for early launch of weight-loss drug Wegovy in India",
    "summary": "Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with rival Eli Lilly in the populous nation, two sources familiar with the plans told Reuters.  Novo, which had earlier planned for a 2026 launch of the drug, is now looking to begin selling Wegovy in India \"this year, probably in the next few months,\" sources told Reuters on condition of anonymity as they were not authorized to talk to the media.",
    "url": "https://finnhub.io/api/news?id=b9037910fe474b06fdeef672bb0c6d8d8d34637bfd0be0e6a87d17ad2a860874",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744039792,
      "headline": "Novo preparing for early launch of weight-loss drug Wegovy in India",
      "id": 133741085,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with rival Eli Lilly in the populous nation, two sources familiar with the plans told Reuters.  Novo, which had earlier planned for a 2026 launch of the drug, is now looking to begin selling Wegovy in India \"this year, probably in the next few months,\" sources told Reuters on condition of anonymity as they were not authorized to talk to the media.",
      "url": "https://finnhub.io/api/news?id=b9037910fe474b06fdeef672bb0c6d8d8d34637bfd0be0e6a87d17ad2a860874"
    }
  },
  {
    "ts": null,
    "headline": "NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare",
    "summary": "CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they are solely prescribed for weight loss.",
    "url": "https://finnhub.io/api/news?id=1ab5d0b1eb383901fd32646ebc59f57731260538db7099efe5442a4696fe9c10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744031640,
      "headline": "NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare",
      "id": 133741086,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they are solely prescribed for weight loss.",
      "url": "https://finnhub.io/api/news?id=1ab5d0b1eb383901fd32646ebc59f57731260538db7099efe5442a4696fe9c10"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Apple, Tesla, GM, JPMorgan, Nvidia, MicroStrategy, Alibaba, Lilly, and More",
    "summary": "Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, while bank stocks such as JPMorgan Chase fall on fears of a global recession.",
    "url": "https://finnhub.io/api/news?id=40476202a94a7d91bf9fd9dd8b66736f451b531769515ff7b4fc9947a87a5da9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744030680,
      "headline": "These Stocks Are Moving the Most Today: Apple, Tesla, GM, JPMorgan, Nvidia, MicroStrategy, Alibaba, Lilly, and More",
      "id": 133738388,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, while bank stocks such as JPMorgan Chase fall on fears of a global recession.",
      "url": "https://finnhub.io/api/news?id=40476202a94a7d91bf9fd9dd8b66736f451b531769515ff7b4fc9947a87a5da9"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes",
    "summary": "Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.",
    "url": "https://finnhub.io/api/news?id=cbecc3924b2c8557ce93a1fc8eeeb9d241d9b78ca1f7b2dad7572c7496db12fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744029420,
      "headline": "Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes",
      "id": 133741088,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.",
      "url": "https://finnhub.io/api/news?id=cbecc3924b2c8557ce93a1fc8eeeb9d241d9b78ca1f7b2dad7572c7496db12fe"
    }
  },
  {
    "ts": null,
    "headline": "Obesity drugs won’t be covered by Medicare under 2026 CMS policy",
    "summary": "This decision is a blow for Eli Lilly and Novo Nordisk, who had both previously endorsed the proposed expansion.",
    "url": "https://finnhub.io/api/news?id=57aef34cf228931da27914a31eb4094317cc4b8283795a78ca01d29006f22607",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744024410,
      "headline": "Obesity drugs won’t be covered by Medicare under 2026 CMS policy",
      "id": 133738578,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "This decision is a blow for Eli Lilly and Novo Nordisk, who had both previously endorsed the proposed expansion.",
      "url": "https://finnhub.io/api/news?id=57aef34cf228931da27914a31eb4094317cc4b8283795a78ca01d29006f22607"
    }
  },
  {
    "ts": null,
    "headline": "Trump rejects Biden administration plan to let Medicare cover obesity drugs",
    "summary": "The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on curbing government spending.",
    "url": "https://finnhub.io/api/news?id=90bffb9bdf01f9a96b061c9c3ffe4a60dc35d04d604188c33bcccd5f0a7632c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744019700,
      "headline": "Trump rejects Biden administration plan to let Medicare cover obesity drugs",
      "id": 133741089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on curbing government spending.",
      "url": "https://finnhub.io/api/news?id=90bffb9bdf01f9a96b061c9c3ffe4a60dc35d04d604188c33bcccd5f0a7632c0"
    }
  },
  {
    "ts": null,
    "headline": "US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree",
    "summary": "The FDA is much more flexible in approving first-in-class drugs compared to European regulators.",
    "url": "https://finnhub.io/api/news?id=190d0bbb9c7bdc053cb664eefdcf3bc706abbf031e324864335ba3c1c6c1e18f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744012800,
      "headline": "US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree",
      "id": 133738580,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The FDA is much more flexible in approving first-in-class drugs compared to European regulators.",
      "url": "https://finnhub.io/api/news?id=190d0bbb9c7bdc053cb664eefdcf3bc706abbf031e324864335ba3c1c6c1e18f"
    }
  },
  {
    "ts": null,
    "headline": "This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.",
    "summary": "This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.",
    "url": "https://finnhub.io/api/news?id=b7ec6c2898e4bf25509b977dd64e9db96e238b62935cf4565e146289f9f5ef27",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743987600,
      "headline": "This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.",
      "id": 133739169,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.",
      "url": "https://finnhub.io/api/news?id=b7ec6c2898e4bf25509b977dd64e9db96e238b62935cf4565e146289f9f5ef27"
    }
  }
]